BioPharma Services Receives Pharma Tech Outlook Top 10 CRO’s of 2022 Award
TORONTO, ON, April 28, 2022 – BioPharma Services Inc. is delighted to announce the acceptance of the Pharma Tech Outlook Top CRO's of 2022 award. Pharma Tech Outlook is a print and digital magazine that provides a knowledge network for scaling pharma technology...
BioPharma’s parent company Think Research progresses the digitization of Phase 1 clinical trials
TORONTO, ON, March 29, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced the launch of its clinical trial Electronic Data Capture (“EDC”)...
Think Research Corporation Closes Acquisition of Bio Pharma Services Inc.
Toronto, ON, September 13, 2021 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has closed its previously announced acquisition of all...
BioPharma Services enhances systems with new Quality Management solution
BioPharma Services is proud to announce that the Dot Compliance suite, a cloud based highly secure Quality Management System (eQMS) solution for life science companies powered by the Salesforce platform, has now been integrated. Salesforce is the leading platform for...
From Surviving To Thriving, BioPharma Addresses Complex Challenges Through Clinical Trials
Surgeons work an average of 60 hours per week in high-pressure environments, after years of medical school and extensive training. This doesn’t consider continuing education, credentialing, on-call responsibilities and much more. For Drs. Fathi Abuzgaya and Esmat...
BioPharma Services Inc. Signs Agreement to be Acquired by Think Research Corporation
On July 15, 2021, BioPharma Services announced that it had entered into a definitive agreement to be acquired by Think Research Corporation. Transaction Highlights: Highly strategic deal will expand THINK’S ability to move data through health systems to deliver better...
Latest FDA Guidance On Bioequivalence Studies During COVID-19
The Food and Drug Administration (FDA) issued a guidance document in January 2021 to provide recommendations to prospective applicants of abbreviated new drug applications (ANDAs) on ensuring the protection of participants when resuming or initiating bioequivalence...
Renzo DiCarlo Of BioPharma Services Inc. Presents COVID-19 Vaccine Strategies To Canadian Parliament
Renzo DiCarlo, CEO of BioPharma Services Inc. was proud to be invited to appear as a witness before the House of Commons’ Standing Committee on International Trade, in view of its study entitled Canada’s International Trade and Investment Policy: Selected...
BioPharma CEO Renzo DiCarlo In Conversation With Brian Crombie
BioPharma Services CEO Renzo DiCarlo spoke to Brian Crombie, host of the popular radio show 'The Brian Crombie Radio Hour' on Sauga 960 AM. During the conversation, Renzo shared his experience leading BioPharma during the COVID-19 pandemic. He also spoke about the...
BioPharma Services Pivots To Provide COVID-19 Testing For Entertainment Industry
Throughout this pandemic we’ve all had to find new ways of working and supporting each other. BioPharma Services has been proud to provide COVID-19 testing services for Private Eyes, the Golden Screen Award-winning hit series starring Canada’s favourite detective duo...
Schedule a Discovery
Call Today
Complete the form to schedule a Discovery Call with one of our medical experts to learn how BioPharma Services can be your trusted clinical trial partner.